# Kyverna Therapeutics, Inc.: Form 8-K, filed Sep 25, 2025

- Company: [Kyverna Therapeutics, Inc.](/companies/kytx.md) (CIK 1994702)
- Form: 8-K
- Filed: 2025-09-25
- Accepted by EDGAR: Sep 25, 2025, 20:05 ET
- Period: 2025-09-19
- Accession: 0001193125-25-217434
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1994702/000119312525217434/kytx-20250919.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1994702/000119312525217434/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1994702/000119312525217434/kytx-20250919.htm

Filed Sep 25, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-217434. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.